Drug search by name

Isavuconazonium Sulfate Capsules and Liver disease

Result of checking the interaction of drug Isavuconazonium Sulfate Capsules and disease Liver disease for safety when used together.

Check result:

Isavuconazonium Sulfate Capsules <> Liver disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of isavuconazonium has been associated with hepatic adverse reactions. Liver function tests should be performed at the start of therapy and periodically in patients with preexisting hepatic abnormalities. Treatment should be withdrawn if persistent elevations or worsening of liver enzyme levels occur. Isavuconazonium has not been studies in patients with severe hepatic impairment (Child-Pugh Class C) and should be used in these patients only when the benefits outweigh the risk.

Isavuconazonium Sulfate Capsules

Generic Name: isavuconazonium

Brand Name: Cresemba

Synonyms: Isavuconazonium, Isavuconazonium Sulfate

What is Isavuconazonium Sulfate Capsules?